Skip to main content

LEVIN CAPITAL STRATEGIES, L.P.

Position in BSX — Boston Scientific Corp

CIK 1354821 NEW YORK, NY

Position in BSX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$9,973,485
New position
Shares Held
158,940
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 0% Shared 55% None 45%

Derivatives in BSX

reported options exposure · as of Mar 31, 2026
CallValue
$62,750
CallShares
1,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

LEVIN CAPITAL STRATEGIES, L.P. holds $15,890,559 across 4 Medical Devices names. BSX ranks #1 (62.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
This page
158,940 $9,973,485

All Filings in BSX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $62,750 1,000
2026-03-31 $9,973,485 158,940